Nelfinavir
Nelfinavir is a pharmaceutical drug with 35 clinical trials. Currently 3 active trials ongoing. Historical success rate of 72.4%.
Success Metrics
Based on 21 completed trials
Phase Distribution
Phase Distribution
18
Early Stage
8
Mid Stage
7
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
65.6%
21 of 32 finished
34.4%
11 ended early
3
trials recruiting
35
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Treating Anemia in Myelofibrosis With Repurposed Drugs (Nelfinavir) That Restore Iron Delivery to the Bone Marrow
Radiosensitizing Effect of Nelfinavir in Locally Advanced Carcinoma of Cervix
Autophagy Maintenance (AUTOMAIN)
Nelfinavir, Cisplatin, and External Beam Radiation Therapy for the Treatment of Locally Advanced Vulvar Cancer That Cannot Be Removed by Surgery
Systemic Therapy and Chemoradiation in Advanced Localised Pancreatic Cancer - 2
Clinical Trials (35)
Treating Anemia in Myelofibrosis With Repurposed Drugs (Nelfinavir) That Restore Iron Delivery to the Bone Marrow
Radiosensitizing Effect of Nelfinavir in Locally Advanced Carcinoma of Cervix
Autophagy Maintenance (AUTOMAIN)
Nelfinavir, Cisplatin, and External Beam Radiation Therapy for the Treatment of Locally Advanced Vulvar Cancer That Cannot Be Removed by Surgery
Systemic Therapy and Chemoradiation in Advanced Localised Pancreatic Cancer - 2
Nelfinavir and Lenalidomide/Dexamethasone in Progressive Multiple Myeloma
Stereotactic Body Radiation With Nelfinavir for Oligometastases
Proton Beam Radiation With Concurrent Chemotherapy and Nelfinavir for Inoperable Stage III Non Small Cell Lung Cancer (NSCLC)
A Phase II Single-arm Intervention Trial of Nelfinavir in Patients With Grade 2/3 or 3 Cervical Intraepithelial Neoplasia
A Study of Nelfinavir Added to Cisplatin Chemotherapy Concurrent With Pelvic Radiation for Locally Advanced Cervical Cancer (II-IVA)
Nelfinavir in Systemic Lupus Erythematosus
A Phase I Trial of Nelfinavir (Viracept ) in Adults With Solid Tumors
Study to Determine the Pharmacokinetic Behavior of Antiretroviral Drugs in Patients Infected by HIV
Nelfinavir in Recurrent Adenoid Cystic Cancer of the Head and Neck
Mechanisms of Lipodystrophy in HIV-Infected Pateints
Nelfinavir as Bortezomib-sensitizing Drug in Patients With Proteasome Inhibitor-nonresponsive Myeloma
A Trial of the Protease Inhibitor Nelfinavir and Concurrent Radiation and Temozolomide in Patients With WHO Grade IV Glioma
Nelfinavir and M8 Drug-level Monitoring in HIV-1 Infection
Evaluation of Nelfinavir and Chemoradiation for Pancreatic Cancer
Dose Escalation Study of Nelfinavir Plus MLN9708 in Patients With Advanced Solid Tumors or Lymphoma
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 35